Beyond the Headline: Decoding the "Worst" Acquisition Cost Ratios in Private Health Insurance
When you see a headline about an insurance company's "worst" acquisition cost ratio, it's easy to jump to conclusions about inefficiency or excessive sales commissions. In the complex world of German private health insurance (Private Krankenversicherung - PKV), the reality is far more nuanced. Recent data reveals a staggering range in these ratios, from a lean 0.94% to a hefty 19.68%. But what do these numbers truly signify? Are high costs always a red flag, or can they indicate strategic investment in a fiercely competitive market? This analysis moves beyond simple cost assessment to explore the strategic realities driving these figures and what they mean for the future of the PKV sector.
What Exactly is the Acquisition Cost Ratio?
The acquisition cost ratio (Abschlusskostenquote) measures a company's expenses related to acquiring new business—including agent commissions, advertising, underwriting, and marketing—as a percentage of its gross earned premiums. In theory, a lower ratio suggests greater operational efficiency, directing more of each premium euro toward reserves and claims rather than sales costs.
However, these ratios have long been a point of controversy, often associated in the public mind with commission excesses, overpriced products, and mis-selling. It's crucial to note that since 2011, German law (§50 of the Insurance Supervision Act - VAG) has capped acquisition commissions in full-coverage health insurance at a maximum of 3% of the gross premium sum for new business. This legal cap means extreme ratios can no longer be blamed solely on runaway commissions.
The Data: A Spectrum from Efficient to High-Spending
According to the latest MAP Report (#925), which analyzes PKV insurers from 2017-2021, the spectrum is wide:
- Best Ratio: Landeskrankenhilfe at 0.94%.
- "Worst" Ratios in Full-Coverage Business: Companies like ARAG reported a ratio of 17.78%. Even higher ratios, such as ERGO's 19.68%, are often attributed to a business focus on supplemental insurance, where different dynamics apply.
If commissions are capped, what explains such dramatic differences? The answer lies in the brutal economics of the modern PKV market.
US Market Comparison: MLR vs. Acquisition Costs
For American readers, a related concept is the Medical Loss Ratio (MLR) in US health insurance, which mandates that 80-85% of premiums be spent on healthcare. The remaining 15-20% covers administration, marketing, and profit. The German acquisition cost ratio zooms in on the sales and marketing portion of that overhead. In both markets, a high percentage dedicated to acquisition can signal either intense competition for customers or, potentially, inefficiency.
Why High Acquisition Costs Are Often a Market Reality, Not a Failure
Labeling a high ratio as "bad" misses critical context. The PKV market for full-coverage (Krankheitskostenvollversicherung) is not a growth market. Between 2011 and 2021, the sector lost 260,000 full-coverage policies. As expert Professor Matthias Beenken notes, significant growth today can only be achieved by taking existing customers from competitors.
This leads to a fundamental truth: Acquiring a new PKV customer is extraordinarily expensive. The sales process is complex, requiring detailed health underwriting and personalized advice. In a stagnant or shrinking pool, insurers must invest heavily in marketing, sophisticated sales tools, and competitive agent incentives just to stand still or gain marginal share. This is an "umdeckungskampf"—a battle to re-deck customers from rivals.
As Reinhard Klages, author of the MAP Report, emphasizes, acquisition costs should not be viewed solely through a cost lens. They represent an investment in the company's future. High spending might reflect a aggressive growth strategy or the high cost of entering a new niche.
Special Case: The Supplemental Insurance (Zusatzversicherung) Market
The analysis becomes even more nuanced for insurers focused on supplemental health insurance. These policies (e.g., for dental, hospital, or alternative medicine) typically have lower premiums than full coverage. However, the sales effort and commission structure can be similar. Consequently, the ratio of acquisition cost to earned premium is naturally higher. A "bad" ratio here may simply reflect the economics of the product type rather than poor management.
| Potential Reason for High Ratio | What It Might Indicate | Is It Necessarily "Bad"? |
|---|---|---|
| Focus on Supplemental Insurance | Lower premium income per policy inflates the cost ratio. | No. This is a structural feature of that business line. |
| Aggressive Growth Strategy | Heavy investment in marketing, digital tools, and agent bonuses to capture market share. | Not inherently. It's a strategic choice that may pay off in future profitability. |
| Defensive Spending in a Stagnant Market | High costs to retain existing agents and prevent customer churn to competitors. | Reflects a tough market environment, not necessarily inefficiency. |
| Inefficient Sales Processes | Outdated distribution models or poor conversion rates from leads to sales. | Yes. This is a genuine operational weakness. |
Conclusion: Look Beyond the Ratio
For insurance advisors and sophisticated consumers, the acquisition cost ratio is a valuable data point, but it is not a standalone verdict. A very low ratio could indicate exceptional efficiency or a lack of investment in growth. A very high ratio could signal a problematic cost structure or a bold investment in future market position.
The key is to ask the right questions: What is the insurer's strategic focus? Is it growing, holding, or shrinking? How does its ratio trend over time? What is its combined ratio (including claims and administration) to assess overall health?
In the high-stakes world of private health insurance, where acquiring a customer is a significant achievement, the cost of that acquisition tells only part of the story. The real measure of success is whether those acquired customers stay, remain healthy contributors to the risk pool, and represent a profitable, long-term relationship for the insurer.
Source: All data is sourced from the current MAP Report #925, the authoritative balance sheet rating for PKV insurers. The full report can be acquired for a fee.